Literature DB >> 25156163

Heritability in frontotemporal dementia: more missing pieces?

Kieren Po1, Felicity V C Leslie, Natalie Gracia, Lauren Bartley, John B J Kwok, Glenda M Halliday, John R Hodges, James R Burrell.   

Abstract

Frontotemporal dementia (FTD) is reportedly highly heritable, even though a recognized genetic cause is often absent. To explain this contradiction, we explored the "strength" of family history in FTD, Alzheimer's disease (AD), and controls. Clinical syndromes associated with heritability of FTD and AD were also examined. FTD and AD patients were recruited from an FTD-specific research clinic, and patients were further sub-classified into FTD or AD phenotypes. The strength of family history was graded using the Goldman score (GS), and GS of 1-3 was regarded as a "strong" family history. A subset of FTD patients underwent screening for the main genetic causes of FTD. In total, 307 participants were included (122 FTD, 98 AD, and 87 controls). Although reported positive family history did not differ between groups, a strong family history was more common in FTD (FTD 17.2 %, AD 5.1 %, controls 2.3 %, P < 0.001). The bvFTD and FTD-ALS groups drove heritability, but 12.2 % of atypical AD patients also had a strong family history. A pathogenic mutation was identified in 16 FTD patients (10 C9ORF72 repeat expansion, 5 GRN, 1 MAPT), but more than half of FTD patients with a strong family history had no mutation detected. FTD is a highly heritable disease, even more than AD, and patients with bvFTD and FTD-ALS drive this heritability. Atypical AD also appears to be more heritable than typical AD. These results suggest that further genetic influences await discovery in FTD.

Entities:  

Mesh:

Year:  2014        PMID: 25156163     DOI: 10.1007/s00415-014-7474-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  37 in total

1.  C9ORF72 repeat expansions in cases with previously identified pathogenic mutations.

Authors:  Marka van Blitterswijk; Matthew C Baker; Mariely DeJesus-Hernandez; Roberta Ghidoni; Luisa Benussi; Elizabeth Finger; Ging-Yuek R Hsiung; Brendan J Kelley; Melissa E Murray; Nicola J Rutherford; Patricia E Brown; Thomas Ravenscroft; Bianca Mullen; Peter E A Ash; Kevin F Bieniek; Kimmo J Hatanpaa; Anna Karydas; Elisabeth McCarty Wood; Giovanni Coppola; Eileen H Bigio; Carol Lippa; Michael J Strong; Thomas G Beach; David S Knopman; Edward D Huey; Marsel Mesulam; Thomas Bird; Charles L White; Andrew Kertesz; Dan H Geschwind; Vivianna M Van Deerlin; Ronald C Petersen; Giuliano Binetti; Bruce L Miller; Leonard Petrucelli; Zbigniew K Wszolek; Kevin B Boylan; Neill R Graff-Radford; Ian R Mackenzie; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers
Journal:  Neurology       Date:  2013-09-11       Impact factor: 9.910

2.  Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

Authors:  Isabelle Le Ber; Eric Guedj; Audrey Gabelle; Patrice Verpillat; Magali Volteau; Catherine Thomas-Anterion; Marielle Decousus; Didier Hannequin; Pierre Véra; Lucette Lacomblez; Agnès Camuzat; Mira Didic; Michèle Puel; Jean-Albert Lotterie; Véronique Golfier; Anne-Marie Bernard; Martine Vercelletto; Christine Magne; François Sellal; Izzie Namer; Bernard-François Michel; Jacques Pasquier; François Salachas; Jean Bochet; Alexis Brice; Marie-Odile Habert; Bruno Dubois
Journal:  Brain       Date:  2006-11       Impact factor: 13.501

3.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

4.  Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.

Authors:  Lieke L Smits; Yolande A L Pijnenburg; Esther L G E Koedam; Annelies E van der Vlies; Ilona E W Reuling; Teddy Koene; Charlotte E Teunissen; Philip Scheltens; Wiesje M van der Flier
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile.

Authors:  Emma Devenney; Michael Hornberger; Muireann Irish; Eneida Mioshi; James Burrell; Rachel Tan; Matthew C Kiernan; John R Hodges
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

6.  SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Elisa Rubino; Innocenzo Rainero; Adriano Chiò; Ekaterina Rogaeva; Daniela Galimberti; Pierpaola Fenoglio; Yakov Grinberg; Giancarlo Isaia; Andrea Calvo; Salvatore Gentile; Amalia Cecilia Bruni; Peter Henry St George-Hyslop; Elio Scarpini; Salvatore Gallone; Lorenzo Pinessi
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

7.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 8.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

9.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

Authors:  Michael J Strong; Gloria M Grace; Morris Freedman; Cathy Lomen-Hoerth; Susan Woolley; Laura H Goldstein; Jennifer Murphy; Christen Shoesmith; Jeffery Rosenfeld; P Nigel Leigh; Lucie Bruijn; Paul Ince; Denise Figlewicz
Journal:  Amyotroph Lateral Scler       Date:  2009-06

10.  Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.

Authors:  Bradley F Boeve; Kevin B Boylan; Neill R Graff-Radford; Mariely DeJesus-Hernandez; David S Knopman; Otto Pedraza; Prashanthi Vemuri; David Jones; Val Lowe; Melissa E Murray; Dennis W Dickson; Keith A Josephs; Beth K Rush; Mary M Machulda; Julie A Fields; Tanis J Ferman; Matthew Baker; Nicola J Rutherford; Jennifer Adamson; Zbigniew K Wszolek; Anahita Adeli; Rodolfo Savica; Brendon Boot; Karen M Kuntz; Ralitza Gavrilova; Andrew Reeves; Jennifer Whitwell; Kejal Kantarci; Clifford R Jack; Joseph E Parisi; John A Lucas; Ronald C Petersen; Rosa Rademakers
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

View more
  12 in total

1.  Mendelian and Sporadic FTD: Disease Risk and Avenues from Genetics to Disease Pathways Through In Silico Modelling.

Authors:  Claudia Manzoni; Raffaele Ferrari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.

Authors:  Clarissa Valdez; Daniel Ysselstein; Tiffany J Young; Jianbin Zheng; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

3.  Neurotransmitter Pathway Genes in Cognitive Decline During Aging: Evidence for GNG4 and KCNQ2 Genes.

Authors:  Luke W Bonham; Daniel S Evans; Yongmei Liu; Steven R Cummings; Kristine Yaffe; Jennifer S Yokoyama
Journal:  Am J Alzheimers Dis Other Demen       Date:  2018-01-16       Impact factor: 2.035

Review 4.  Genetic testing in dementia - utility and clinical strategies.

Authors:  Carolin A M Koriath; Joanna Kenny; Natalie S Ryan; Jonathan D Rohrer; Jonathan M Schott; Henry Houlden; Nick C Fox; Sarah J Tabrizi; Simon Mead
Journal:  Nat Rev Neurol       Date:  2020-11-09       Impact factor: 42.937

5.  Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease.

Authors:  Jennifer S Yokoyama; Luke W Bonham; Renee L Sears; Eric Klein; Anna Karydas; Joel H Kramer; Bruce L Miller; Giovanni Coppola
Journal:  BMC Neurol       Date:  2015-03-28       Impact factor: 2.474

6.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

7.  Intrafamilial Phenotypic Variability in the C9orf72 Gene Expansion: 2 Case Studies.

Authors:  David Foxe; Elle Elan; James R Burrell; Felicity V C Leslie; Emma Devenney; John B Kwok; Glenda M Halliday; John R Hodges; Olivier Piguet
Journal:  Front Psychol       Date:  2018-09-03

8.  Heritability in frontotemporal tauopathies.

Authors:  Shelley L Forrest; Glenda M Halliday; Heather McCann; Andrew B McGeachie; Ciara V McGinley; John R Hodges; Olivier Piguet; John B Kwok; Maria G Spillantini; Jillian J Kril
Journal:  Alzheimers Dement (Amst)       Date:  2019-01-24

Review 9.  An update on genetic frontotemporal dementia.

Authors:  Caroline V Greaves; Jonathan D Rohrer
Journal:  J Neurol       Date:  2019-05-22       Impact factor: 4.849

10.  The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications.

Authors:  Helena Gossye; Christine Van Broeckhoven; Sebastiaan Engelborghs
Journal:  Front Neurosci       Date:  2019-08-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.